Across TCGA pan-cancer cohorts, USP9YP28 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated USP9YP28 data layer.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher USP9YP28 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated USP9YP28 expression acts as an unfavorable survival marker.
COAD, MESO, and PRAD are the cancer types where USP9YP28 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.